CCR5 delta32 deletion and response to highly active antiretroviral therapy in HIV-1-infected patients

AIDS. 2000 Dec 1;14(17):2788-90. doi: 10.1097/00002030-200012010-00020.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-HIV Agents / therapeutic use*
  • Antiretroviral Therapy, Highly Active*
  • Cohort Studies
  • Follow-Up Studies
  • Genotype
  • HIV Infections / drug therapy*
  • HIV Infections / genetics*
  • Humans
  • Logistic Models
  • Odds Ratio
  • Receptors, CCR5 / genetics*
  • Receptors, CCR5 / metabolism*
  • Sequence Deletion / genetics*
  • Treatment Outcome

Substances

  • Anti-HIV Agents
  • Receptors, CCR5